All In Biotech

Drug Trial Radar · NCT01473524

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

A Phase 3, Double-Blind, Placebo-Controlled Trial and Long-Term Safety Extension of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Last checked: Nov 19, 2026Latest source record: May 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 217 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

217

Actual

Start

Jan 2012

Primary completion

Dec 2013

Study completion Dec 17, 2018

Sponsor

Lead sponsor
Intercept PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Nov 17, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objectives of the study were to assess the effects of Obeticholic Acid (OCA) on serum alkaline phosphatase (ALP) and total bilirubin, together as a composite endpoint and on safety in participants with primary biliary cirrhosis (PBC).

Conditions

  • Primary Biliary Cirrhosis

Interventions

  • Obeticholic Acid (OCA)Drug

    OCA was administered orally once daily and provided in tablet form in 2 strengths: 5 mg and 10 mg.

  • PlaceboDrug

    Matching placebo tablets were administered orally once daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DB Phase: Composite Endpoint Alkaline Phosphatase (ALP) And Total Bilirubin, 10 mg OCA Versus PlaceboTime frame: DB Month 12
  2. LTSE Phase: Composite Endpoint ALP And Total BilirubinTime frame: Baseline (DB Month 12), LTSE Months 24, 36, 48, and 60

Locations

59 sites in 13 countries. Site status is shown where the registry gives one.

  • UC Davis Medical Center

    Sacramento, California

  • Scripps Clinic

    San Diego, California

  • University of Colorado, Denver

    Aurora, Colorado

  • University of Chicago

    Chicago, Illinois

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Henry Ford Health System

    Detroit, Michigan

  • St. Louis University

    St Louis, Missouri

  • Beth Israel Medical Center

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • Liver Institute of Virginia

    Newport News, Virginia

  • Liver Institute of Virginia

    Richmond, Virginia

  • Virginia Commonwealth University/McGuire DVAMC

    Richmond, Virginia

  • Swedish Medical Center

    Seattle, Washington

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Austin Hospital

    Heidelberg, Victoria, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • Medizinische Universität Innsbruck

    Innsbruck, Austria

  • Medizinische Universität Wien

    Vienna, Austria

  • UZ Leuven

    Leuven, Belgium

  • Toronto Western Hospital Liver Centre

    Toronto, Ontario, Canada

  • CHUM Hôpital St-Luc

    Montreal, Quebec, Canada

  • Hopital Haut-Leveque

    Pessac, France

  • Universitätsklinikum Aachen

    Aachen, Germany

  • Friedrich-Alexander-Universität Erlangen

    Erlangen, Germany

  • Klinikum der Johann-Wolfgang Goethe Universität Frankfurt am Main

    Frankfurt am Main, Germany

  • Universitätsklinikum Hamburg Eppendorf

    Hamburg, Germany

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Medizinische Universitätsklinik

    Heidelberg, Germany

  • Gastroenterologische Gemeinschaftspraxis, Dres. Felten / Hartmann / Hüppe

    Herne, Germany

  • Universitätsklinikum des Saarlandes

    Homburg, Germany

  • Universitätsklinikum Leipzig

    Leipzig, Germany

  • LMU Klinikum der Universität München

    München, Germany

  • Dip. Medicina Clinica - Università di Bologna

    Bologna, Italy

  • Dip. Medicina Clinica- Università di Bologna

    Bologna, Italy

  • Azienda Ospedaliera di Padova - Gastroenterologia

    Padova, Italy

  • Istituto Clinico Humanitas

    Rozzano (MI), Italy

  • VUmc Amsterdam

    Amsterdam, Netherlands

  • AMC Amsterdam

    Amsterdam, Netherlands

Showing 40 of 59 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.